The effects of 1,4-dichlorobenzene (DCB) have been compared in male F344 rats given 0 (corn oil control), 25, 75, 150, and 300 mg/kg DCB and male B6C3F, mice given 0 (corn oil control), 300, and 600 mg/kg DCB by daily oral gavage five days per week for 1,4, and 13 weeks. The two highest rat and both mouse dose levels were the same as those employed in a NTP bioassay, where DCB produced kidney tumors in male rats and liver tumors in mice. DCB produced significant dose-related increases in relative liver weight in both the rat and the mouse which was associated with, respectively, mild and marked centrilobular hypertrophy. Administration of DCB also produced a sustained induction of microsomal cytochrome P450 content and 7-pentoxyresorufin O-depentylase activity in both species. Western immunoblotting studies demonstrated that DCB induced CYP2B isoenzyme(s) in both rat and mouse liver microsomes. Replicative DNA synthesis was studied by implanting osmotic pumps containing 5-bromo-2'-deoxyuridine in study Weeks 0-1, 3-4, and 12-13. In the rat hepatocyte labeling index values were only increased in animals given 300 mg/kg DCB for 1 week, whereas hepatocyte labeling index values were significantly increased in mice given 300 and 600 mg/kg DCB for 1 and 4 weeks. DCB treatment produced significant increases in rat renal Pi/P 2 proximal tubule cell labeling index values at all time points, whereas little effect was observed in mouse kidney. The observed species difference in DCB-induced liver tumor formation may reflect the greater sensitivity of the mouse to tumor promotion by a CYP2B inducer. For the kidney, the present data provides further evidence that while DCB-induced a 2 irglobulin nephropathy is associated with a sustained stimulation of cell replication in male rat renal proximal tubule cells, this effect is not observed in the male mouse, o 1997 Soda? of Toxicology.
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1,4-Dichlorobenzene (DCB; CAS 106-46-7) is a volatile organic solid used as a space deodorant, a moth repellent, and as an intermediate in organic syntheses (NTP, 1987) . Studies into the metabolism of DCB have indicated that the 'To whom correspondence should be addressed. Fax: 44-(0)181- 661-7029. major metabolites are the glucuronide and sulfate conjugates of 2,5-dichlorophenol (Azouz et al., 1955; Hawkins et al, 1980; Klos and Dekant, 1994) . Human hepatic cytochrome P450 isoenzymes which can metabolize DCB to 2,5-dichlorophenol include CYP1A2 and CYP2E1 (Bogaards et al, 1995) . Studies into the acute toxicity of DCB and its isomers have demonstrated that 1,2-dichlorobenzene is more toxic to rat and mouse liver and to rat kidney than 1,3-dichlorobenzene and DCB (Allis et al, 1992; Valentovic et al., 1993; Umemura et al., 1996) .
DCB is considered to be a nongenotoxic agent as demonstrated by results of a number of short-term tests for mutagenic and genotoxic potential (Loeser and Litchfield, 1983; NTP, 1987; Steinmetz et al, 1988) . The carcinogenicity of DCB has been evaluated in a 2-year study in F344 rats and B6C3F, mice (NTP, 1987) . DCB was administered by gavage in corn oil 5 days per week at doses of 150 and 300 mg/kg to male F344 rats and 300 and 600 mg/kg to female rats and male and female B6C3F| mice. While DCB was not carcinogenic in female F344 rats, a dose-related increase in renal tubular cell adenocarcinomas was observed in male F344 rats and liver tumors were observed in both male and female B6C3F, mice (NTP, 1987) . The incidences of hepatocellular adenoma or carcinoma in male mice given 0, 300, and 600 mg/kg DCB were 34, 45, and 80%, respectively, whereas for female mice the incidences were 30, 21, and 72%, respectively (NTP, 1987) .
DCB has been shown to stimulate replicative DNA synthesis both in rodent hepatocytes and in male rat renal proximal tubule cells. In the liver DCB is a mitogenic agent, unlike its isomers 1,2-and 1,3-dichlorobenzene, in that it stimulates cell proliferation without producing hepatic injury (Eldridge et al., 1990 (Eldridge et al., , 1992 Umemura et al., 1992 Umemura et al., , 1996 . However, in the male rat kidney DCB is nephrotoxic and the stimulation of cell replication in renal proximal tubule cells is due to a regenerative hyperplasia (Steinmetz et al., 1988; Charbonneau et al, 1989; Borghoff et al, 1990; Eldridge et al, 1990; Dietrich and Swenberg, 1991a; Umemura et al, 1992) . DCB is known to be one of a number of nongenotoxic chemicals which can produce nephropathy and renal tumors in male rats, but not in female rats or in other species such as mice, guinea pigs, dogs, and monkeys Borghoff et al, 1990) . Such chemicals or their metabolites bind to the male rat-specific protein a 2u -globulin which prevents proteolytic hydrolysis and leads to accumulation of a 2U -globulin in protein droplets (lysosomes). This results in the degeneration and necrosis of individual cells of the P 2 segment of the kidney proximal tubule and a subsequent sustained regenerative hyperplasia Borghoff et al, 1990 Borghoff et al, , 1993 Dietrich and Swenberg, 1991a) .
The aim of the present study was to obtain further information on the mechanisms underlying the observed species and tissue differences in DCB-induced tumor formation. Male rats and mice of the strains used in the DCB bioassay (NTP, 1987) were treated with DCB for periods of 1, 4, and 13 weeks. The effect of DCB on replicative synthesis in the liver and kidney and on some parameters of hepatic xenobiotic metabolism has been investigated.
MATERIALS AND METHODS

Chemicals.
DCB (>99%), 5-bromo-2'-deoxyuridine (BRDU), enzyme cofactors, etc., were obtained from Sigma-Aldrich Chemical Co. Ltd. (Poole, Dorset, UK). Western immunoblotting kits with enhanced chemiluminescence reagents and rabbit antibodies to rat CYP2B1/2 and CYP3A were obtained from Amersham International pic (Little Chalfont, Bucks, UK).
Animals and treatment
Male F344 rats and male B6C3F, mice were obtained from Harlan Olac (Bicester, Oxon, UK) and were allowed free access to R and M No. 1 diet (Special Diets Services, Witham, Essex, UK) and water. The animals were housed in groups of three in mesh-floored cages in accommodation maintained at 22 ± 3°C with a relative humidity of 40-70% and were allowed to acclimatize to these conditions for at least 14 days before the study began. Rats (9 weeks old) and mice (9 weeks old) were treated with 25-600 mg/day DCB by daily oral gavage 5 days per week. Control animals received corresponding quantities (5 ml/kg) of the com oil vehicle. Animals were killed by carbon dioxide asphyxiation followed by cervical dislocation.
Replicative DNA synthesis and liver morphology. Replicative DNA synthesis was studied by subcutaneously implanting Alzet (Charles River UK Ltd, Margate, Kent, UK) osmotic pumps (rats Model 2ML1, mice Model 2001) containing 15 mg/ml BRDU during Study Weeks 0-1, 3-4, and 12-13. The osmotic pumps were implanted 1 day before the commencement of the 5 days of DCB dosing. Sections of liver (two from the left lobe and one each from the right, median, right caudal, and caudate lobes), left kidney, and upper small intestine (to confirm pump efficiency) were fixed in neutral buffered formalin. After the sections were processed, immunostaining of dewaxed 5-/im sections was performed with an anti-BRDU antibody and 3,3'-diaminobenzidine (Barrass et al, 1993) . The hepatocyte labeling index (i.e., percentage of hepatocyte nuclei undergoing replicative DNA synthesis) was assessed by microscopic examination of at least 1000 nuclei in random fields from the left lobe. Morphological examination was performed on liver sections from all lobes. The labeling index of the combined renal P, and P 2 proximal tubule cells was assessed by microscopic examination of at least 1500 nuclei in random fields of the outer cortex, whereas the labeling index of the P 3 renal proximal tubule cells was determined by microscopic examination of at least 1500 nuclei in random fields from the outer stripe of the outer medulla (Short et al., 1987) .
Biochemical investigations.
Liver whole homogenates (rat 0.25 and mouse 0.1 g fresh tissue/ml) were prepared in ice-cold 0.154 M KC1 con- taining 50 mM Tris-HCl, pH 7.4, employing a Potter-type, Teflon-glass, motor-driven homogenizer (A. H. Thomas Co., Philadelphia, PA). Washed microsomal fractions were prepared by differential centrifugation (Lake, 1987) and assayed for cytochrome P450 content (Omura and Sato, 1964) and activities of 7-ethoxyresorufin O-deethylase, 7-pentoxyresorufin O-depentylase, and erythromycin yV-demethylase (Lake, 1987; Japenga et al, 1993) . Protein was determined by the method of Lowry et al. (1951) employing bovine serum albumin as standard. Washed microsomal fractions were subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis and Western immunoblotting as described previously (Japenga et al, 1993; . Immunoreactive bands were detected by enhanced chemiluminescence reagents employing the manufacturers instructions.
Statistical analysis. Statistical evaluation of data was performed by one-way analysis of variance. Comparisons between means were made using the least significant difference test RESULTS DCB was administered to male F344 rats at dose levels of 0 (corn oil control), 25, 75, 150, and 300 mg/kg and to male B6C3F, mice at dose levels of 0 (corn oil control), 300, and 600 mg/kg by daily oral gavage 5 days per week. The two highest rat dose levels and both mouse dose levels are those employed in the DCB bioassay (NTP, 1987) . Animals were killed approximately 24 hr after the fifth DCB dose during study Weeks 1, 4, and 13.
Effect on Body Weight and Relative Organ Weights
DCB treatment at 300 mg/kg for 1 week and 150 and 300 mg/kg for 13 weeks produced small reductions in body weight gain in the rat (Fig. 1A) . Treatment with 300 and 600 mg/kg DCB had no effect on body weight gain in the mouse (Fig. IB) . In the rat treatment with 300 mg/kg DCB produced significant increases in relative liver weight (i.e., liver weight/100 g body wt) at all time points (Fig. 1C ). Significant increases in relative liver weight were also observed in rats given 75 and 150 mg/kg DCB for 4 weeks and 150 mg/kg DCB for 13 weeks (Fig. 1C) . The administration of 300 and 600 mg/kg DCB to mice resulted in significant increases in relative liver weight at all time points ( ID). Significant increases in relative kidney weight were observed in rats given 150 and 300 mg/kg DCB for 4 and 13 weeks (Fig. IE) , whereas the treatment of mice with 300 and 600 mg/kg DCB had no significant effect on relative kidney weight (Fig. IF) .
Effect on Liver Morphology
Morphological examination of liver sections was confined to rats given 0 and 300 mg/kg DCB and mice given 0 and 600 mg/kg DCB for 1 and 13 weeks. DCB treatment for 1 week did not produce any morphological changes in the rat, whereas in the mouse a minimal centrilobular hypertrophy was observed. A mild centrilobular hypertrophy was observed in liver sections from rats given 300 mg/kg DCB for 13 weeks, whereas in mice given 600 mg/kg DCB a marked centrilobular hypertrophy was observed. No other histological abnormalities were observed in liver sections from rats given 300 mg/kg DCB and mice given 600 mg/kg DCB for 1 and 13 weeks.
Effect on Replicative DNA Synthesis in Hepatocytes and
Renal Proximal Tubule Cells
Replicative DNA synthesis was determined in Study Weeks 0-1,3-4, and 12-13using osmotic pumps to continuously administered BRDU which were implanted 1 day prior to 5 days of DCB treatment. The labeling index values reported in this paper are thus for 6-day periods of which DCB was administered for the last 5 days before necropsy.
The treatment of rats with 300 mg/kg DCB for 1 week significantly increased the hepatocyte labeling index to 255% of control ( Fig. 2A) . No significant increases were observed in hepatocyte labeling index values in rats given 25-150 mg/ kg DCB for 1 week and 25-300 mg/kg DCB for 4 and 13 weeks ( Fig. 2A ). Significant increases in hepatocyte labeling index values to 475 and 1175% of control and to 420 and 395% of control were observed in mice given 300 and 600 mg/kg DCB for 1 and 4 weeks, respectively (Fig. 2B) .
The effect of DCB administration to rats (Figs. 3 A and 3C) and mice (Figs. 3B and 3D ) on replicative DNA synthesis in combined P^ renal proximal tubule cells (Figs. 3A and 3B) and in P 3 renal proximal tubule cells (Figs. 3C and 3D ) was determined. In rat Pi/P 2 renal proximal tubule cells the labeling index was significantly increased to 170% of control by treatment with 300 mg/kg DCB for 1 week (Fig. 3A) . Significant increases in Pi/P 2 labeling index values to 250, 400, and 475% of control were observed in rats given 75, 150, and 300 mg/kg DCB, respectively, for 4 weeks and to 440 and 775% of control in rats given 150 and 300 mg/kg DCB, respectively, for 13 weeks (Fig. 3A) . Mouse P,/P 2 renal tubular cell labeling index values were not significantly increased by DCB treatment for 1 and 13 weeks (Fig. 3B) . However, mouse P1/P2 cell labeling index values were sig- nificantly increased to 205 and 170% of control by treatment with 300 and 600 mg/kg DCB, respectively, for 4 weeks (Fig. 3B ). Some*reduction of rat P 3 renal proximal tubule cell labeling index values was observed in rats given 75-300 mg/kg DCB for 1 week, whereas significant increases to 185 and 485% of control were observed in rats given 300 mg/kg DCB for 4 and 13 weeks, respectively (Fig. 3C) . In contrast, treatment with 300 and 600 mg/kg DCB for 1, 4, and 13 weeks had little effect on mouse P 3 renal proximal tubule cell labeling index values (Fig. 3D) .
Effect on Hepatic Xenobiotic Metabolism
Treatment with DCB significantly induced parameters of hepatic xenobiotic metabolism in both the rat and the mouse. Significant dose-related increases in microsomal cytochrome P450 content were observed in rats given 150 and 300 mg/ kg DCB for 1 week, 25-300 mg/kg DCB for 4 weeks, and Immunoblots of hepatic microsomal fractions incubated with antibodies to rat CYP2B1/2 (A) and rat CYP3A (B). Microsomal fractions (20 /ig protein per lane) were prepared from pooled liver samples from mice treated with 0 (corn oil control), 300, and 600 mg/kg DCB (lanes 1, 2, and 3, respectively) and rats treated with 0 (corn oil control), 75, and 300 mg/kg DCB (lanes 4, 5, and 6, respectively) for 1 week.
75-300 mg/kg DCB for 13 weeks (Fig. 4A) . Microsomal cytochrome P450 content was significantly induced in mice given 600, but not 300, mg/kg DCB for 1, 4, and 13 weeks (Fig. 4B) . A significant dose-related induction of microsomal 7-pentoxyresorufin 0-depentylase activity was observed in rats given 75-300 mg/kg DCB for 1 and 4 weeks and 25-300 mg/kg DCB for 13 weeks (Fig. 4C> . DCB treatment at dose levels of 300 and 600 mg/kg also significantly induced 7-pentoxyresorufin O-depentylase activity in mouse liver microsomes (Fig. 4D) . Over the 1-, 4-, and 13-week treatment periods the ranges of induction of enzyme activity in rats given 300 mg/kg DCB and mice given 300 and 600 mg/ kg were 5245-7555, 290-410, and 615-785% of control, respectively.
Additional investigations were conducted with hepatic microsomal preparations from rats treated with 150 and 300 mg/kg DCB and mice treated with 600 mg/kg DCB for 1 week. Microsomal protein content was significantly increased in rats given 300 mg/kg DCB and mice given 600 mg/kg DCB to 130 and 110% of control, respectively (Table  1) . 7-Ethoxyresorufin O-deethylase activity in rats given 150 and 300 mg/kg DCB and mice given 600 mg/kg DCB was significantly induced to 275, 415, and 325% of control, respectively. Corresponding values for induction of erythromycin /V-demethylase were 115, 155, and 200% of control, respectively (Table 1) . Microsomal fractions from rats given 0, 75, and 300 mg/kg DCB and mice given 0, 300, and 600 mg/kg DCB were subjected to sodium dodecyl sulfatepolyacrylamide gel electrophoresis and probed with antibodies to rat CYP2B1/2 and CYP3A. Although no immunoreactive bands were observed in control mouse liver microsomal fractions probed with the rat CYP2B1/2 antibody, a marked dose-related induction was observed in liver microsomal fractions from mice treated with 300 and 600 mg/kg DCB (Fig. 5A, lanes 1-3) . With control rat liver microsomes two immunoreactive bands were observed with the rat CYP2B1/ 2 antibody, of which the higher molecular weight band was induced by treatment with 75 mg/kg DCB and both bands were induced by treatment with 300 mg/kg DCB (Fig. 5A,  lanes 4-6) .
Immunoreactive bands were detected in all mouse and rat liver microsomal fractions probed with the rat CYP3A antibody (Fig. 5B) . While no marked induction of CYP3A was observed in liver microsomal fractions from mice treated with 300 and 600 mg/kg DCB (Fig. 5B, lanes 1-3) and rats given 75 mg/kg DCB (Fig. 5B, lanes 4 and 5) , some induction of CYP3A was observed in rats given 300 mg/kg DCB (Fig. 5B, lane 6) .
DISCUSSION
The results of this study demonstrate that DCB can produce a stimulation of cell replication in both rat and mouse hepatocytes, but only stimulates cell replication in male rat and not in male mouse renal proximal tubule cells. The results of the liver cell replication studies are broadly in agreement with previous short-term (<7 days) studies (Eldridge et al, 1990; Umemura et al, 1992 Umemura et al, , 1996 and the 13-week study of Eldridge et al. (1992) where cell replication was studied in male and female B6C3F, mice and in female, but not male, F344 rats. With respect to the male rat kidney, the present data extends the previous short-term studies of up to 3 weeks duration in the male rat and provides cell replication data for treatment periods of > 1 week in the male mouse. DCB-induced replicative DNA synthesis in rat hepatocytes was observed at the highest dose examined after 1, but not after 4 and 13, weeks of treatment. In the mouse, hepatocyte labeling index values were significantly increased at both bioassay dose levels after 1 and 4, but not 13, weeks of treatment. At the respective bioassay dose levels DCB thus appears to produce a more marked stimulation of cell replication in male mouse than in male rat hepatocytes and in the mouse the stimulation of cell replication persists for up to 4 weeks (Fig. 2) .
Many studies have demonstrated that cell proliferation is an important factor in the development of carcinogenicity by both genotoxic and nongenotoxic chemicals (Butterworth, 1991; Cohen and Ellwein, 1991; Ames et al, 1993; Weisburger, 1994) . DCB is a nongenotoxic agent (Loeser and Litchfield, 1983; NTP, 1987; Steinmetz et al, 1988 ), which appears to produce an additive hyperplasia in rodent liver and a regenerative hyperplasia in male rat kidney. While increased cell proliferation has been implicated in the formation of tumors in rodents by various classes of nongenotoxic carcinogens (Loury et al., 1987; Butterworth, 1991; Cohen and Ellwein, 1991; Grasso and Hinton, 1991; Ames et al., 1993; Lake, 1995; Cunningham, 1996; Lake and Grasso, 1996) , a correlation between increased cell replication and carcinogenesis is not always observed (Melnick and Huff, 1993; Melnick et al, 1996) . In the present study replicative DNA synthesis was increased in both species after acute DCB treatment, whereas in the NTP bioassay DCB produced liver tumors only in the mouse. The mouse liver is the most common site of tumor formation in rat and mouse NTP bioassays (Haseman and Clark, 1990; Ward et al., 1996) . Although the mitogenic effects of DCB were greater in mouse than in rat hepatocytes, increased cell proliferation per se is unlikely to be solely responsible for the observed species differences in liver tumor formation (NTP, 1987) . Such data highlight the potential pitfalls of cell replication studies, particularly when an increase is observed only after acute administration of the test chemical. Rather cell replication data needs to be considered with other properties of the test chemical such as promotional effects (see below) and effect on apoptosis (Goldsworthy et al, 1996) .
The present data demonstrate that the mitogenic effects of DCB in rat and mouse liver are associated with the induction of xenobiotic metabolizing enzymes. For example, doserelated increases in cytochrome P450 content and 7-pentoxyresorufin Odepentylase activity were observed throughout the 13-week treatment period (Fig. 4) . Additional studies were performed with liver microsomal fractions from animals treated with DCB for 1 week (Table 1 and Fig. 5 ). The activities of 7-ethoxyresorufin 0-deethylase, 7-pentoxyresorufin 0-depentylase, and erythromycin N-demethylase may be taken as markers for induction of cytochrome P450 isoenzymes in the CYP1A, CYP2B, and CYP3A subfamilies, respectively (Burke et al, 1985; Lubet et al, 1990; Murray and Reidy, 1990; Nelson et al, 1996) . In the rat DCB markedly induced 7-pentoxyresorufin O-depentylase and also stimulated erythromycin N-demethylase suggesting induction of CYP2B and CYP3A isoenzymes. This pattern of enzyme induction was confirmed by the Western immunoblotting studies where DCB markedly induced rat hepatic microsomal CYP2B1/2 and also produced some increase in CYP3A. DCB also induced 7-pentoxyresorufin and erythromycin metabolism in mouse liver microsomes and a marked induction of CYP2B isoenzyme(s) was observed by Western immunoblotting with the antibody to rat CYP2B1/2. Although DCB treatment produced small increases in 7-ethoxyresorufin activity in both rat and mouse liver microsomes, such increases probably do not imply induction of CYP1A isoenzymes. CYP1A enzyme inducers, such as finaphthoflavone, produce very marked increases in this enzyme activity in rodent liver microsomes, whereas small increases are produced by non-CYPl A inducers such as phenobarbital (Burke et al, 1985; Lubet et al, 1990; Japenga et al, 1993) . Based on the parameters measured in this study DCB appears to be a more potent inducer of hepatic xenobiotic metabolism in the rat than in the mouse.
While the induction of hepatic xenobiotic metabolism in the rat and mouse could be further characterized, the present results suggest that DCB is a CYP2B inducer in these species with properties similar to those of phenobarbital, l,l-bis(4-chlorophenyl)-2,2,2-trichloroethane (DDT), chlordane, and other compounds (Nims and Lubet, 1996) . Such agents can also induce cytochrome P450 isoenzymes in other subfamilies including CYP2C and CYP3A (Nims and Lubet, 1996) . Like phenobarbital, in both the rat and the mouse DCB increased relative liver weight, produced centrilobular hypertrophy, and stimulated replicative DNA synthesis after acute, but not chronic, administration (Grasso and Hinton, 1991; Cunningham, 1996; Orton et al, 1996; Whysner et al, 1996) . Phenobarbital and related compounds can act as tumor promotors in the rat and mouse (Nims and Lubet, 1996; Whysner et al, 1996) and other studies have demonstrated that the mouse is more susceptible than the rat to liver tumor formation by nongenotoxic agents including phenobarbital, DDT, chlordane, and dieldrin (Loury etai, 1987; Grasso and Hinton, 1991) .
The mechanisms(s) of liver tumor formation by CYP2B inducers such as phenobarbital remain to be fully elucidated. However, the mitogenic and promotional effects of these agents are clearly important and phenobarbital, for example, has been reported to elicit different effects on normal and initiated hepatocytes (Grasso and Hinton, 1991; Jirtle, 1994; Andersen et al., 1995; Goldsworthy et al., 1996) . Mechanistic studies with phenobarbital and other tumor promoters support a general model of promotion involving negative selection, where specifically mutated cells derive a growth advantage in the presence of persistent mitosuppression by agents such as transforming growth factor-/^ (Andersen et al., 1995) . The present data suggest that promotional and other effects of a phenobarbital-type enzyme inducer may be important in the formation of mouse liver tumors by DCB and may account for the observed species difference in hepatocarcinogenicity (NTP, 1987) .
Previous studies have demonstrated that DCB is one of a number of compounds, including ^-limonene, 2,2,4-trimethylpentane, and unleaded gasoline, which can produce a 2U -globulin nephropathy in male rats but not in female rats or other species including the mouse (Short et al., 1987 Charbonneau et al., 1989; Swenberg et al, 1989; Borghoff et al, 1990 Borghoff et al, , 1993 Dietrich and Swenberg, 1991a; Flamm and Lehman-McKeeman, 1991) . Increased cell proliferation, primarily in P 2 renal proximal tubule cells, is a key event in tumor formation and no increased cell replication is observed in male NCI-Black-Reiter rats, which lack a 2U -globulin and are not susceptible to renal disease by DCB and other chemicals known to produce a 2ir globulin nephropathy (Dietrich and Swenberg, 1991b,c) . As in studies with 2,2,4-trimethylpentane, unleaded gasoline, and other compounds, the effects of DCB on replicative DNA synthesis were sustained throughout the treatment period and a greater effect was observed in renal Pi/P 2 than in P 3 proximal tubule cells Swenberg et al, 1989) . In contrast to the rat, DCB produced little effect on cell replication in mouse renal proximal tubule Pi/P 2 and P 3 cells (Figs. 3B  and 3D ). The small increases in P,/P 2 tubular cell labeling index values after 4, but not 1 and 13, weeks DCB treatment may be due to low control values at this timepoint.
The effect of DCB treatment on cell proliferation in renal proximal tubule cells of the male rat and male mouse over the 13 weeks of this study are in agreement with the observed species differences in formation of renal tubular cell adenocarcinomas. In the NTP bioassay the incidences of renal tubular cell adenocarcinomas in male rats given 0, 150, and 300 mg/kg DCB were 2, 6, and 14%, respectively (NTP, 1987) . These increases occurred with a significant positive trend and the incidence in the high DCB dose group was significantly greater than the vehicle controls (NTP, 1987) . In the present study DCB treatment at both male rat bioassay doses, but not the lower doses of 25 and 75 mg/kg, resulted in significant increases in renal proximal tubule Pi/P 2 cell labeling index values after 4 and 13 weeks (Fig. 3A) . Such data suggest that a clear dose threshold exists for DCBinduced cell proliferation and subsequent tumor formation in male F344 rat kidney.
In summary, the observed species differences in DCBinduced liver tumor formation may reflect the greater sensitivity of the mouse to CYP2B tumor promoters such as phenobarbital. With the kidney the present data provide further evidence that while DCB and related compounds produce a 2U -globulin nephropathy, which is associated with a sustained stimulation of cell replication, in male rat renal proximal tubule cells, this effect is not observed in other species such as the mouse.
